HIV News and Research

RSS

Urine LAM-ELISA's sensitivity of 50.7% in identifying TB disappoints

Urine LAM-ELISA does not appear to be useful as an independent diagnostic test for pulmonary tuberculosis (TB). A trial of the new diagnostic, described in the open access journal BMC Infectious Diseases found that it was only capable of identifying 50.7% of TB cases.

28 Aug 2009

NIMH grants Xhale $1.7 million to develop the SMART medication adherence system for HIV/AIDS therapies

Xhale, Inc. has been awarded a $1.7 million Small Business Innovation Research (SBIR) Phase II grant by the NIH National Institute of Mental Health (NIMH) to continue the development of SMART (Self Monitoring and Reporting Therapeutics), a breath-based medication adherence system for HIV/AIDS therapies.

28 Aug 2009

Town halls: Even tempers prevail in Wisconsin, but not Phoenix

In Eau Claire, Wisconsin, Rep. Ron Kind, D-Wis, encountered something Democrats may have become unaccustomed to: "a fairly even-tempered crowd" at an "intimate" town hall meeting, Roll Call reports. Kind voted against the reform proposal in the House Ways and Means Committee, but defended current incarnations of the overhaul package during a meeting with local business owners and state National Federation of Independent Business representatives.

28 Aug 2009

Also in global health news: NTD study; false cholera cases in Zimbabwe; contaminated water in Kenya; doctor's strike ends

UPI reports on a recent review article in the journal PLoS Neglected Tropical Diseases that analyzed the toll of neglected tropical diseases on populations in sub-Saharan Africa. "Researchers said helminth (parasitic worm) infections account for approximately 85 percent of the neglected tropical diseases, which overall might be equivalent to more than double that caused by tuberculosis and as much as half of the area's malaria disease burden," the news service writes (8/26).

28 Aug 2009

Viral Genetics cautions investors and the public to rely only on its own releases and disclosures

Viral Genetics (Pink Sheets: VRAL), a biotechnology company that develops drug compounds for HIV/AIDS, autoimmune diseases, and cancer, is issuing this announcement in response to a series of press releases distributed by collegestock.com on August 25 and August 26, and an article published on Today's Financial News entitled "TFN Reader Grapevine: There's Something About Viral Genetics, Inc. (VRAL)," on August 25.

27 Aug 2009

EDCTP welcomes proposals for tuberculosis vaccines and HIV/AIDS treatment projects

EDCTP welcomes project proposals as a response to the following calls: Tuberculosis vaccines, HIV/AIDS treatment and Member States Initiated projects.

27 Aug 2009

XenaCare Holdings to market Cobroxin pain reliever drug in U.S.

Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it has successfully completed a licensing agreement that grants XenaCare Holdings (OTCBB:XCHO) ongoing exclusive United States marketing and distribution rights for Cobroxin in return for meeting specific minimum performance requirements.

27 Aug 2009

Lakewood-Amedex to speed up development of its broad spectrum anti-influenza product into clinical studies

Lakewood-Amedex Inc., (L-A), the anti-infectives biopharmaceutical company developing a unique portfolio of anti-bacterial and anti-viral products including NuBiotics, a novel family of synthetic anti-bacterial compounds, and anti-viral products against hepatitis, HIV and influenza, announced today that it is accelerating development of its broad spectrum anti-influenza product into clinical studies.

27 Aug 2009

BioAlliance Pharma posts revenue of €4.1 million for the first half of 2009

BioAlliance Pharma SA (Paris:BIO) (Euronext Paris – BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, today presented its consolidated half-year accounts to June 30, 2009.

27 Aug 2009

US Department of Health funds a project to enhance the quality of care to women of color suffering from HIV/AIDS

Dr. S. Vincent Grasso, a member of the Stevens Healthcare Information Technology Management Advisory Board and Seminar Leader for the Stevens Healthcare Educational Partnership (SHEP), will act as technical lead, solution provider and systems integrator within a nation-wide initiative to enhance the quality of care to women of color suffering from HIV/AIDS. The US Department of Health and Human Services is the funding agency for the project, which will be implemented in urban centers across America.

27 Aug 2009

Largest non-profit HIV/AIDS healthcare provider mourns Senator Kennedy's death

AIDS Healthcare Foundation (AHF), the nation’s largest non-profit HIV/AIDS healthcare provider which now provides treatment and services for more than 100,000 individuals in 21 countries worldwide in the US, Africa, Latin America/Caribbean and Asia, today mourned the passing of Senator Ted Kennedy (D, MA) who died late Tuesday at his home in Hyannis Port, MA.

27 Aug 2009

Lancet series examines health issues in South Africa

The journal Lancet published a series of articles examining health issues in South Africa, suggesting that "South Africa's health system is failing women and children in particular, but that new leadership could solve many of the problems," the Associated Press/msnbc.com reports (8/24).

27 Aug 2009

Teenagers who work longer hours in adult environment are associated with riskier sexual behavior

Allowing teens to work too many hours in the wrong environment can be dangerous for their sexual health by fostering conditions that lead them to older sex partners, a new study shows.

26 Aug 2009

UT Southwestern awarded $763,000 as grant to expand studies of Peregrine's anti-PS antibodies

Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced that the U.S. National Institute of Allergy and Infectious Diseases (NIAID) has awarded a two-year, $763,000 grant to Philip Thorpe, Ph.D., of the University of Texas Southwestern Medical Center for research expanding its studies of anti-phosphatidylserine (anti-PS) antibodies as potential treatments for viral hemorrhagic fever (VHF) infections.

26 Aug 2009

Quality test for Guardian Technologies International's Signature Mapping TBDx system completed

Guardian Technologies International, Inc. (OTCBB: GDTI) today announced that its Software Quality Assurance Team has completed all unit, component, integration, and systems tests of Signature Mapping TBDx™ (TBDx™) in preparation for September clinical trials in South Africa.

26 Aug 2009

Sebelius names Chair of Presidential Advisory Council on HIV/AIDS

HHS Secretary Kathleen Sebelius on Monday named Helene Gayle, president and chief executive of the charity CARE USA, as the chair the Presidential Advisory Council on HIV/AIDS, Reuters reports.

26 Aug 2009

California AIDS Clearinghouse to close after cut in social service funding

A casualty of California Governor Arnold Schwarzenegger's draconian cuts in social service funding, the California AIDS Clearinghouse will close next week. The L.A. Gay & Lesbian Center, which operated the program for more than 15 years, received notification from the state Office of AIDS that all funding for it had been eliminated.

26 Aug 2009

The SaniGuard dry-on-contact sanitising spray is launched by MisterSterile.com

A sanitising spray that kills 99.99% of Viruses, Bacteria and Germs is now available for purchase in the UK. The SaniGuard wipes, spray and fogger products were invented by David Morgan, president of DEM Technology in the United States. After patenting the product he was awarded EPA registration for its use on food contact surfaces in 1996.

25 Aug 2009

TuBerculosis Vaccine Initiative receives $3 million grant from Gates Foundation

TuBerculosis Vaccine Initiative (TBVI) recently received a $3million grant for a three year term from the Bill & Melinda Gates Foundation. This grant enables the nonprofit organization to strengthen its fundraising and communication activities in order to increase awareness and support for tuberculosis (TB) vaccine research and raise funds for the development of safer and more effective vaccines.

25 Aug 2009

Health and Human Services Secretary to appoint Helene Gayle as the Chair of Presidential Advisory Council

Today, Secretary of Health and Human Services Kathleen Sebelius announced her intent to appoint Helene Gayle, MD, MPH to serve as the Chair of the Presidential Advisory Council on HIV/AIDS. Secretary Sebelius made the announcement in Atlanta at the 2009 National HIV Prevention Conference.

25 Aug 2009

HIV News and Research

Urine LAM-ELISA's sensitivity of 50.7% in identifying TB disappoints

NIMH grants Xhale $1.7 million to develop the SMART medication adherence system for HIV/AIDS therapies

Town halls: Even tempers prevail in Wisconsin, but not Phoenix

Also in global health news: NTD study; false cholera cases in Zimbabwe; contaminated water in Kenya; doctor's strike ends

Viral Genetics cautions investors and the public to rely only on its own releases and disclosures

EDCTP welcomes proposals for tuberculosis vaccines and HIV/AIDS treatment projects

XenaCare Holdings to market Cobroxin pain reliever drug in U.S.

Lakewood-Amedex to speed up development of its broad spectrum anti-influenza product into clinical studies

BioAlliance Pharma posts revenue of €4.1 million for the first half of 2009

US Department of Health funds a project to enhance the quality of care to women of color suffering from HIV/AIDS

Largest non-profit HIV/AIDS healthcare provider mourns Senator Kennedy's death

Lancet series examines health issues in South Africa

Teenagers who work longer hours in adult environment are associated with riskier sexual behavior

UT Southwestern awarded $763,000 as grant to expand studies of Peregrine's anti-PS antibodies

Quality test for Guardian Technologies International's Signature Mapping TBDx system completed

Sebelius names Chair of Presidential Advisory Council on HIV/AIDS

California AIDS Clearinghouse to close after cut in social service funding

The SaniGuard dry-on-contact sanitising spray is launched by MisterSterile.com

TuBerculosis Vaccine Initiative receives $3 million grant from Gates Foundation

Health and Human Services Secretary to appoint Helene Gayle as the Chair of Presidential Advisory Council

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News